Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Investor Relations RE: GSA Press Release

From Investor Relations RE: GSA Press Release

posted on Apr 28, 2009 11:10AM

Dear XXXXXXXXX:
Regarding the timing of the GSA press release: Even after the award, there were several procedural and technical steps we needed to accomplish in order to facilitate the functioning of the relationship and complete the award process. Those were our priority and focus, and once those were addressed and approved by the GSA Vendor Support Center, we then issued the public announcement.
Best Regards,
Angela Hartley
Investor Relations

From:
Sent: Fri 4/24/2009 9:11 PM
To: Investor Relations
Subject: GSA PR

Dear Ms. Hartley,

The GSA awarded Crossflo in March, 2009...... Why did PTS wait until April 23, 2009 to PR it?

Share
New Message
Please login to post a reply